Foundation Medicine’s Breakthrough Personalized Cancer Care Relies on Thermo Scientific Nautilus LIMS
Founded by world leaders in genome technology, cancer biology and medical oncology, Foundation Medicine is a cancer diagnostics company at the forefront of bringing comprehensive genomic analysis to routine cancer care. The Cambridge, Mass.-based company’s clinical laboratory services help physicians and their patients develop customized cancer treatment and therapy based on an individual tumor’s molecular subtype. Key to this process is Foundation Medicine’s Next-Generation Sequencing (NGS) platform, which extracts relevant genomic information from small amounts of cancer tissue. The organization’s revolutionary process requires precise management of data collected from disparate sources, so Foundation uses Thermo Scientific Nautilus LIMS to integrate its lab, clinical and EMR information.